Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Monsanto releases rice data to academia

Article Abstract:

Monsanto, St. Louis, MO, completed a draft of the genetic sequence of rice, Oryza sativa, and will share the information free of charge to academic researchers.

Author: Niiler, Eric
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
Rice, Rice Farming

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


GM corn pses little threat to monarch

Article Abstract:

Despite reports by researchers at Cornell University of genetically modified pollen killing monarch butterfly larvae, the Agricultural Biotechnology Stewardship Working Group reported at a symposium that limited pollen drift and lower than previously reported toxicity will not cause significant death.

Author: Niiler, Eric
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 1998
Product standards, safety, & recalls, Corn, Corn Farming

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Monsanto remains a magnet for GM opposition

Article Abstract:

Scientists from the Center for Ethics and Toxics, CA, and the University of Cincinnati College of Medicine revealed that the Roundup-Ready soybean of Monsanto, genetically modified to be resistant to its Roundup herbicide, is 12-14% lower in isoflavones than natural soybeans.

Author: Niiler, Eric
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 1999
Product information, Soybean Farming, Soybeans, Monsanto Co., MTC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Plant genetics
Similar abstracts:
  • Abstracts: Global warming push aims to renew green PR passion. Mad cow disease: it just won't go away. KFC fights e-rumor of 'Frankenchickens'
  • Abstracts: On strategy: paying for performance. Preparing to promote. On strategy: preparing to promote
  • Abstracts: Gene pill patents a surprise for gene therapy. US FDA approves new class of HIV therapeutics. First round to Amgen in EPO battle
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.